Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue: +3.71%
EPS: +10.2%
Free cash flow: −24.9%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

121.59 2.46 +2.06%

Follow GRAL

Alert me

Market cap: $5.3B
P/E: 0.0×
Fwd P/E: −14.5×
Dividend yield: —
F-score: 6/9
Altman Z: 0.37
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

GRAIL, Inc. 10-K filed Mar 5, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Mar 5, 2025 · accepted 4:29 PM ET · Document on sec.gov · Filing index

Red flags

Impairment Mar 5, 2025
GRAIL, Inc. recorded a goodwill impairment of $888.9 million in fiscal 2024

10-K filed Mar 5, 2025 · The filing · sec.gov